In a notice posted past due Saturday on its Web site, the State Meals and Medication Administration said it acquired suspended the sale of methotrexate made by Shanghai Hualian Pharmaceutical Co. Ltd. The declaration said it caused adverse reactions in several young leukemia individuals in hospitals of Guangxi autonomous area in southern China and the eastern financial center of Shanghai. ‘A few of the children have felt pain in their legs and some have experienced difficulty in walking after getting injected with the methotrexate medication numbered 070403A and 070403B,’ the statement said.‘That is an investigational gadget that may be a game-changer due to the size and the technology housed within it,’ says Dr. Robert C. Kowal, MD, PhD, principal investigator because of this trial at BHVH. Fifty establishments around the world are taking part in the trial. One-tenth how big is a typical pacemaker, the Micra TPS is normally delivered straight into the center through a catheter inserted in the femoral vein . Once positioned, the pacemaker is securely mounted on the heart wall and will be retrieved or repositioned if needed. Related StoriesARCA biopharma announces genetic screening of 1st patient in GENETIC-AF Stage 2B/3 medical trialFirst Edition: June 3, 2014Richard M. Ross Heart Medical center docs implanted smallest center pacemaker in Columbus girl’This miniaturized technology is made to provide individuals with the advanced pacing technology of traditional pacemakers with a minimally invasive strategy.